Skip to main content
Nanomedicine

Nanomedicine

Inhalable nanosensors could increase access to lung cancer screening

08 Feb 2024 Tami Freeman
The PATROL diagnostic platform uses inhalable nanoparticle sensors
Inhale and detect The PATROL diagnostic platform incorporates inhalable nanoparticle sensors and low-cost lateral flow assays. The lower panel shows a scanning electron micrograph of the particles, which are coated with nanosensors that interact with cancer-associated proteins in the lungs. (Courtesy: CC BY-ND/MIT researchers)
Low-dose CT, the gold standard technique for diagnosing lung cancer in at-risk groups, has reduced l

You’ve reached the limit of what you can view on Physics World without registering

If you already have an account on Physics World, then please sign in to continue reading

If you do not yet have an account, please register so you can

  • Access more than 20 years of online content
  • Choose which e-mail newsletters you would like to receive
Copyright © 2024 by IOP Publishing Ltd and individual contributors